SCI时时刷

search
Preoperative Carcinoembryonic Antigen as a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff
Preoperative Carcinoembryonic Antigen as a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff
Carcinoembryonic antigen (CEA) is an important prognostic factor for rectal cancer. This study aims to introduce a novel c...
Prevalence and Risk Factors of Acute Kidney Injury After Colorectal Cancer Surgery
Prevalence and Risk Factors of Acute Kidney Injury After Colorectal Cancer Surgery
Acute kidney injury is a sentinel event affecting colorectal cancer patients either as a consequence of surgery or systemi...
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is projected to be the second leading cause of cancer-related death by 2030. Early...
Curative-Intended Management of Synchronous Esophageal and Rectal Cancer—A Systematic Literature Review
Curative-Intended Management of Synchronous Esophageal and Rectal Cancer—A Systematic Literature Review
Synchronous esophageal (EC) and rectal carcinoma (RC) is a rare and challenging condition, particularly in curative-intend...
Development of a Prognostic Nomogram for Overall Survival in Gastric Cancer Patients Who Underwent Adjuvant Chemoradiotherapy
Development of a Prognostic Nomogram for Overall Survival in Gastric Cancer Patients Who Underwent Adjuvant Chemoradiotherapy
The aim of this study was to identify prognostic factors influencing overall survival (OS) in patients with gastric cancer...
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with limited therapeutic options and poor progno...
Gender, Race, and Regional Disparities in Leading Authorships of Gastroenterology and Hepatology Randomized Controlled Trials
Gender, Race, and Regional Disparities in Leading Authorships of Gastroenterology and Hepatology Randomized Controlled Trials
To investigate gender, racial, ethnic, and regional disparities in first and senior authorship positions in gastroenterolo...
Clinical Outcomes and Prognosis of Esophageal Squamous Cell Carcinoma Presenting with Obstruction
Clinical Outcomes and Prognosis of Esophageal Squamous Cell Carcinoma Presenting with Obstruction
The prognosis of esophageal squamous cell carcinoma (ESCC) with obstruction is unclear. This study aimed to analyze clinic...
Demographics, Prognostic Factors, and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective Analysis
Demographics, Prognostic Factors, and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective Analysis
Hepatic angiosarcoma (HA) is a rare malignant vascular neoplasm. Currently, there are no standardized protocols for treati...
Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma
Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma
The clinicoradiological staging for esophageal cancer is fraught with variable accuracy, potentially depriving patients wh...
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
MET amplification (amp) is a driver of acquired resistance to epidermal growth factor receptor (EGFR) antibodies in patien...
Anti-EGFR Rechallenge in Metastatic Colorectal Cancer and the Role of ctDNA: A Systematic Review and Meta-analysis
Anti-EGFR Rechallenge in Metastatic Colorectal Cancer and the Role of ctDNA: A Systematic Review and Meta-analysis
Metastatic colorectal cancer (mCRC) remains a significant clinical challenge. While anti-EGFR inhibitors have improved sur...
Immunohistochemical Expression of ROR2 in Gastrointestinal Stromal Tumor
Immunohistochemical Expression of ROR2 in Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors affecting the digestive tract, comprising ap...
Factors Influencing Immunotherapy Utilization in Stage IV Pancreatic Cancer: Impact of Race and Socioeconomics in the U.S
Factors Influencing Immunotherapy Utilization in Stage IV Pancreatic Cancer: Impact of Race and Socioeconomics in the U.S
Pancreatic ductal adenocarcinoma (PDAC), a highly lethal cancer with a poor prognosis, is expected to become the second de...
Prognostic Effect of the PNI and LSR in Patients with Esophageal Squamous Cell Carcinoma Patients Receiving Radiotherapy
Prognostic Effect of the PNI and LSR in Patients with Esophageal Squamous Cell Carcinoma Patients Receiving Radiotherapy
The prognostic nutritional index (PNI) has been used to assess the immunonutritional status of cancer patients and can pre...
Third- or Further-Line Treatment in Patients with MSS Type Metastatic Colorectal Cancer
Third- or Further-Line Treatment in Patients with MSS Type Metastatic Colorectal Cancer
The survival benefit from later-line treatment for patients with metastatic colorectal cancer (mCRC) remains disappointing...
Unexpected Multiple Gastrointestinal Cancers in a Patient with Chronic Eosinophilia: A Case Report
Unexpected Multiple Gastrointestinal Cancers in a Patient with Chronic Eosinophilia: A Case Report
While the relationship between eosinophilia and tumors has been extensively studied, eosinophilia is primarily observed cl...